Does sildenafil (Viagra) use increase the risk of pulmonary embolism in patients with a history of hypertension (HTN)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Sildenafil (Viagra) does not appear to increase the risk of pulmonary embolism in patients with hypertension, and its use is generally safe when blood pressure is adequately controlled and nitrates are not being taken. The medication works by inhibiting phosphodiesterase type 5 (PDE5), increasing cyclic GMP levels which promotes smooth muscle relaxation in the corpus cavernosum and pulmonary vasculature, facilitating erection and reducing pulmonary vascular resistance respectively 1.

Key Considerations

  • Sildenafil can cause modest drops in blood pressure, so hypertensive patients should ensure their blood pressure is well-controlled before using the medication 2, 3, 4.
  • The combination of sildenafil with nitrates (like nitroglycerin) is absolutely contraindicated as it can cause dangerous hypotension 2, 5, 3, 4.
  • Patients with cardiovascular disease, including those with hypertension, can generally use sildenafil safely when their condition is stable and they are not taking contraindicated medications 5, 1.
  • The standard dosing for erectile dysfunction typically starts at 50mg taken approximately one hour before sexual activity, with adjustments between 25-100mg based on response and tolerability 2, 4.

Safety and Efficacy

  • Sildenafil has been shown to be effective and safe in patients with erectile dysfunction, including those with hypertension and cardiovascular disease 2, 5, 3, 4, 1.
  • The medication has minimal adverse effects in men with stable ischemia, hypertension, and/or severe coronary artery disease 1.
  • Sildenafil has been found to decrease both elevated pulmonary vascular resistance and elevated pulmonary artery pressures in patients with pulmonary vascular disease 1.

References

Research

Sildenafil in patients with cardiovascular disease.

The American journal of cardiology, 2003

Research

Cardiovascular risk and sildenafil.

The American journal of cardiology, 2000

Research

Viagra and Cardiovascular Disease.

Journal of cardiovascular pharmacology and therapeutics, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.